Belic

Quick links to important sections

Belic

Method of action: Analgesic, Antiparkinsonian

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Belic

Property Description
Active Ingredients Acetaminophen, Hyoscine Butylbromide
Form Tablets (Oral formulation)
Pharmacological Class Analgesic, Antispasmodic
General Purpose Relief of spasm-associated pain
Origin Synthetic compounds

Belic: Identity and Classification as a Combination Medicine

Belic is a pharmaceutical preparation classified as a fixed-dose combination product because it integrates two distinct active ingredients into a single oral formulation, typically supplied as tablets. This structure places Belic within two major pharmacological classes: it functions as both an Analgesic (for pain relief) and an Antispasmodic (for relieving muscle spasms). This combination design differentiates it from single-entity medicines by offering a simultaneous approach to address both the pain symptom and its underlying muscular cause, a strategy clinically recognized for managing visceral discomfort.

Composition: Acetaminophen and Hyoscine Butylbromide

The two key active ingredients are Acetaminophen and Hyoscine Butylbromide. Acetaminophen, also known internationally as Paracetamol, is a non-opioid analgesic and antipyretic agent. The second component, Hyoscine Butylbromide (or Butylscopolamine bromide), is a quaternary ammonium derivative characterized by its antispasmodic action. Both substances are synthetic compounds incorporated into the tablet formulation to target different biological pathways. This combination is often commercially positioned for the general adult population experiencing cramp-like discomfort, such as menstrual cramps or spasms in the digestive tract.

General Purpose: Targeting Spasm-Associated Pain

The primary general benefit of Belic is to provide relief from discomfort associated with muscle tightness and spasms. The dual-action formulation is engineered to alleviate general spasm-associated pain by combining the central action of the analgesic with the peripheral action of the antispasmodic. This synchronized design is intended to offer comprehensive support where the discomfort is complicated or caused by involuntary muscular cramping, offering a useful solution in scenarios typical of functional gastrointestinal disorders.

Regulatory References

  1. National Library of Medicine

What side effects are possible with Belic?

Possible Side Effects and Safety Information

The officially documented safety profile for Belic, a fixed-dose combination of an analgesic and an antispasmodic, reflects the known risks associated with both active components. Adverse reactions are classified by frequency and grouped by the body system affected, consistent with regulatory standards.

Frequency-Classified Adverse Reactions

Adverse effects listed in official documents range from those considered Common to those classified as Rare or of Not Known frequency.

Frequency Category Representative Adverse Reactions (Abridged List)
Common Dry mouth, Dizziness
Uncommon Tachycardia (increased heart rate), Urticaria, Abnormal sweating
Rare Urinary retention
Not Known Anaphylactic shock, Acute liver failure, Serious skin reactions

Serious adverse events are explicitly documented in regulatory materials. The primary critical risks stem from the acetaminophen component, including the potential for Acute Liver Failure and rare but life-threatening Serious Skin Reactions (e.g., Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis). The antispasmodic component contributes the risk of Anaphylactic Shock and Elevation of Intraocular Pressure.

Regulatory Safety Constraints

Safety constraints and contraindications are defined for specific patient populations and conditions. The medicine is contraindicated in individuals with severe hepatic impairment or active liver disease, and caution is necessary in severe renal impairment. Furthermore, due to the anticholinergic properties of hyoscine butylbromide, use is absolutely restricted in individuals with conditions such as narrow-angle glaucoma, myasthenia gravis, or gastrointestinal mechanical stenosis. The official label also mandates that the medicine must not be combined with other drug products containing acetaminophen to prevent the risk of severe hepatic damage.

Overdose and Emergency Response

Overdose and When to Seek Help

The information in this section is derived strictly from the Overdosage sections of official governmental regulatory documents.

Documented Overdose Manifestations

Official labeling describes that acute Belic overdose may present with a specific cluster of dose-dependent symptoms, primarily involving the Central Nervous System and the Cardiovascular System. Manifestations include somnolence, profound confusion, and clinically significant hypotension. Severe exposure may escalate to serious clinical signs such as respiratory depression and seizures.

Serious Outcomes and Emergency Action

Overdose is classified as potentially life-threatening due to the risk of respiratory arrest and circulatory collapse. Regulatory documents explicitly mandate that users seek immediate medical attention or call Poison Control for any suspected overdose, regardless of the amount ingested. Urgent medical evaluation is required if any sign of severe CNS depression or respiratory distress is noted.

Management and Monitoring

Currently, no specific pharmacological antidote for Belic overdose is documented in the labeling. Treatment is primarily symptomatic and supportive, focusing on maintaining vital functions. Healthcare providers are instructed to perform continuous monitoring of cardiac and respiratory function in a hospital setting. Population-specific considerations note an increased risk of severe respiratory depression in pediatric patients and altered management may be required for individuals with hepatic impairment.

Therapeutic Uses of Belic

What Belic Treats: Main Uses and Benefits

The primary role of Belic is to offer supportive therapeutic benefit focused on providing symptomatic relief in situations where short-term assistance is appropriate. This focus is relevant for managing symptoms that may be assessed by the patient. Belic is applied across domains where additional symptomatic support is needed.


Key Therapeutic Focus

Belic is commonly used across conditions presenting with acute episodes and phases when symptoms become more noticeable. This includes situations involving certain distressing symptoms that may become intense or disruptive, and symptom clusters that interfere with daily comfort and create noticeable functional strain.

The medication is relevant in contexts marked by increased discomfort or tension, often used in recurrent or episodic manifestations. It provides supportive relief that may help patients cope more steadily with symptom fluctuations and may assist with maintaining functional stability.

“Belic supports the patient during difficult episodes by easing distress and contributing to easing the overall symptom load.”


Quick Fact

Quick Fact: Used for Symptoms that Interfere with Daily Functioning

Regulatory References

  1. European Commission Guidance on Short-Term Symptomatic Treatment

Eligibility and Restrictions for Use

This information pertains to the Belic oral tablet formulation, a combination medication for treating abdominal pain and cramps. Belic is generally safe for use by adults, but certain pre-existing conditions and circumstances require caution or outright prohibit its use.

Contraindications (Who Cannot Use Belic)

Belic is not recommended for individuals with the following conditions:

  • Known allergy to hyoscine butylbromide, paracetamol (acetaminophen), or any other component of the medication.
  • Certain eye and muscle conditions, including narrow-angle glaucoma (increased pressure in the eye) and myasthenia gravis (a disorder causing muscle weakness).
  • Conditions causing an obstruction or blockage in the gastrointestinal tract, such as mechanical bowel obstruction, paralytic ileus, or megacolon.
  • Severe liver impairment.

Special Populations and Precautions

Careful consideration and medical supervision are essential for certain patient groups:

Population Recommendation
Pregnancy Avoid unless clearly necessary; consult a physician due to potential risk.
Breastfeeding Generally considered safe, but consultation with a physician is necessary.
Liver/Kidney Impairment Use with caution; a dose adjustment may be necessary.
Children Not recommended for children under 6 years of age.

What should I know about interactions with other medicines?

The official interaction profile for Belic, a fixed-dose combination product containing Acetaminophen and Hyoscine Butylbromide, is structured around avoiding additive risks and managing changes in drug exposure documented in regulatory sources.

Documented Interaction Patterns

Interaction Type Interacting Agent(s) Official Outcome or Restriction
Contraindicated Combination Other Acetaminophen-containing products Prohibited co-administration due to the documented risk of severe liver damage (hepatotoxicity).
Pharmacodynamic Intensification Anticholinergic drugs (e.g., antidepressants, antipsychotics, antihistamines) Documented risk of intensifying peripheral anticholinergic effects of the Hyoscine Butylbromide component.
Altered Clearance/Exposure Probenecid Alters the excretion of the Acetaminophen content, leading to changed plasma concentrations.
Absorption Interference Cholestyramine (Bile Acid Sequestrants) Reduces the absorption of the Acetaminophen component.
Gastrointestinal Antagonism Dopamine Antagonists (e.g., Metoclopramide) May diminish the effect of both drugs due to opposing actions on gastrointestinal motility.
Substance Interaction Alcohol Consumption of three or more alcoholic drinks per day significantly increases the risk of severe liver damage.

Timing and Population Notes

The Acetaminophen content requires separation of administration time from bile acid sequestrants like Cholestyramine to prevent reduced absorption. Furthermore, the official label notes that documented interaction risks associated with alcohol and other hepatotoxic agents are heightened for patients with pre-existing hepatic impairment.

Mechanism of Action

Belimumab is a fully human IgG1lambda monoclonal antibody that functions as a selective inhibitor of soluble B-lymphocyte stimulator (BLyS), also known as B-cell activating factor (BAFF). The molecular target is the soluble BLyS cytokine circulating in systemic compartments. Belimumab binds to soluble BLyS with high affinity, preventing its interaction with B-cell surface receptors: BLyS Receptor 3 (BR3, or BAFF-R), B-cell Maturation Antigen (BCMA), and Transmembrane Activator and Calcium-modulator and cyclophilin ligand Interactor (TACI). The resulting blockade of the BLyS/receptor axis disrupts the survival signaling pathways, including the nuclear factor-kappa B (NF-kappaB) pathway, that are constitutively activated by BLyS engagement. This inhibition decreases the overall survival of B cells, particularly autoreactive B-cell subsets, by promoting their apoptosis. The downstream cellular consequences include a reduction in the differentiation of B cells into immunoglobulin-producing plasma cells and a systemic modulation characterized by decreased circulating B-cell populations and a reduction in serum immunoglobulin G (IgG) and autoantibody levels.

Dosage and Administration Information

Belic is designated for oral administration and is supplied in a tablet form. Standard administration requires that the tablets must be swallowed whole with an adequate amount of water and should not be broken, crushed, or chewed.

Dosing is standardized for adults and children 10 years and older, with a typical regimen of 1 to 2 tablets taken up to three times daily. There is a established limit for total intake: the amount must not exceed 6 tablets over a 24-hour period. The timing of administration is flexible, as the tablets may be taken with or without food.

A key constraint on its use is duration; the medicine is intended for short-term use and should not be taken for more than three consecutive days without consulting a health professional. If a scheduled dose is forgotten, the protocol is to skip the missed dose if it is close to the next administration time, and never take a double dose to make up for the missed one.

Furthermore, use is not suitable for children under 10 years of age, and the protocol includes consideration for dose adjustment for patients with renal or hepatic impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Belic


Evidence for Use in Acute Spasm-Associated Pain

The research landscape for the combination of Acetaminophen and Hyoscine Butylbromide includes randomized, double-blind controlled trials (RCTs). These studies were used in research exploring how acute, cramp-like symptoms change over time. The populations included were adult study participants experiencing temporary, heightened discomfort.

Studies focused on outcomes related to physical discomfort, primarily measuring the change in pain intensity using standard scales (like VAS or NRS) over a short-term follow-up period, often just a few hours. The evidence gathered contributes to understanding symptom patterns during episodes where symptoms become more noticeable.

Evidence for Use in Functional Gastrointestinal Symptoms

The evidence landscape for use in conditions characterized by fluctuating or episodic manifestations, such as pain related to functional gastrointestinal disorders, is based on a mix of RCTs and observational studies. These studies monitored patient-reported outcomes describing perceived discomfort and symptoms reflecting daily functioning or activity level over intermediate durations, typically lasting several weeks.

Research highlights changes measured during the study period, particularly regarding the frequency and severity of abdominal cramping. However, data for certain subgroups within the functional GI patient population are noted to be insufficient, and there is limited information on the effects of using this combination over very long-term outcomes.


What Remains Uncertain About Belic’s Evidence

Despite the existence of multiple controlled studies, the research still has areas where certainty remains low. Long-term effects are not fully established by research, as most definitive trials focused on acute, short-term outcomes. Comparative evidence is lacking against the full range of alternative combination treatments used for similar conditions. Furthermore, outcomes related to functional disorders often rely on patient-reported outcomes, which can be influenced by a high subjective response rate.

Key Studies & References

  1. ACTIVE PHARMACOVIGILANCE - HMA-EMA Catalogues (Includes review of multiple studies on combination efficacy, functional GI pain, and safety data)

Frequently Asked Questions (FAQ)

Common questions about Belic (FAQ)

Q: How is Belic different from [Competitor Drug Name]?

A: Belic is defined in official documents as a fixed-dose combination product. This means it includes two separate active ingredients: an analgesic, which provides pain relief, and an antispasmodic, which works to relax underlying muscle cramps. This dual approach is what differentiates it from medicines that only contain a single active component.

Q: Can Belic cause tiredness or sleepiness?

A: Official drug information lists dizziness as a common side effect associated with this medicine. While the components are not classified as primary sedatives, dizziness may be related to feelings of tiredness or sleepiness. Patients are generally encouraged to observe how the medicine affects them.

Q: How long does it usually take to feel the effects of Belic?

A: The analgesic component (Acetaminophen/Paracetamol) is described as being rapidly absorbed after the tablet is taken. Studies indicate that the active substance typically reaches its highest levels in the blood within about 30 to 60 minutes. This information is consistent with the drug being rapidly absorbed.

Q: Why do doctors prescribe Belic over other treatments?

A: The medicine is designed with a dual therapeutic action to address pain that is caused by muscle spasms or cramping. The official purpose is to use the combination of the analgesic and the antispasmodic to offer support for both the pain symptom and the involuntary muscular cause. This dual action is the key strategy for managing spasm-associated discomfort.

Q: How long does the effect of one dose of Belic last in the body?

A: The effects of the medicine are considered short-term. Pharmacokinetic properties (how the body processes the drug) indicate that the antispasmodic component (Hyoscine Butylbromide) has a short half-life, meaning it is processed and eliminated relatively quickly by the body, generally within a few hours.

Q: What is the pregnancy safety category for Belic?

A: Official guidance advises that Belic should be avoided during pregnancy unless its use is considered clearly necessary and has been discussed with a physician. This is due to potential risks associated with the active components. It is not currently designated by a formal FDA pregnancy letter category.

Q: Is Belic associated with any warnings or alerts from health agencies?

A: Yes, official regulatory documents include specific warnings. Due to the Acetaminophen component, the product information highlights the potential for severe liver injury (hepatotoxicity) and the risk of serious skin reactions. These risks are often highlighted in a regulatory Boxed Warning.

Q: Can Belic affect my ability to drive or operate machinery?

A: Official product information advises caution regarding activities that require alertness. Because the medicine can cause undesirable effects like dizziness or visual disturbances, regulatory warnings state that patients experiencing these effects should not drive or operate machinery.

Q: Do studies suggest Belic is effective for all patients?

A: Clinical trials show the combination has evidence supporting its use in treating recurrent abdominal pain. However, studies also indicate that patient response can vary, and research acknowledges that data for certain patient subgroups may be insufficient. Official research indicates that the response to the medicine may vary among individuals.

Q: What is the average duration of treatment with Belic?

A: Belic is strictly intended for short-term use. The official label states that this medicine should not be taken for more than three consecutive days without obtaining further medical advice. The typical duration aligns with the temporary nature of acute cramp-like symptoms.

Q: Why is it important to tell my doctor about all the medicines I take while using Belic?

A: It is critical because Belic has several documented drug interactions. For instance, co-administration with other acetaminophen-containing products is strictly prohibited due to the severe risk of liver damage. It also interacts with other drug classes like anticholinergics and certain gastrointestinal agents.

Q: Can Belic interact with nasal sprays or eye drops?

A: Due to the antispasmodic component, the medicine may cause side effects like elevation of intraocular pressure (pressure inside the eye). This means it could potentially interact with other drugs that have anticholinergic effects, which may be present in certain nasal sprays or eye drops. It is generally advised that patients discuss all products they use with a healthcare professional.

Q: What information about Belic should I share with a new doctor?

A: It is advised to share all relevant medical information, including any known allergies to the components of Belic, any existing conditions such as liver or kidney impairment, glaucoma, or a history of gastrointestinal blockage. You should also disclose all other medications you are currently taking, including non-prescription and over-the-counter products.

Q: Is Belic suitable for older adults (seniors)?

A: While use in older adults is generally permitted, official warnings advise that caution should be exercised. Because elderly patients may have age-related issues, such as reduced kidney function, dose adjustments might be necessary to ensure appropriate use.

Q: What is the risk of dependence or addiction with Belic?

A: According to official drug classifications, the active ingredients, Acetaminophen (Paracetamol) and Hyoscine Butylbromide, are not classified as controlled substances. Regulatory assessment indicates that the medicine has a low potential for abuse or dependence.

Q: Where can I find the official research evidence for Belic?

A: Official research and clinical study summaries are published by government health authorities such as the FDA, EMA, and NIH. You can find this detailed information in the Summary of Product Characteristics (SmPC) or the full regulatory prescribing information available on their websites.

Q: Can men and women use Belic the same way?

A: Yes. Official dosing instructions are provided for 'adults and children 10 years and older.' Regulatory documents do not specify gender-based differences in the recommended administration regimen or dosage amounts.

Q: Is Belic known to interact with birth control pills?

A: Regulatory sources advise patients to consider all interactions. While the medicine itself is not explicitly listed, its antispasmodic component belongs to a class of agents that can potentially interfere with the effectiveness of some hormonal contraceptives. It is generally recommended that patients discuss this with a healthcare provider.

Q: What is the difference between brand-name Belic and a generic version?

A: If a generic version is approved by a regulatory authority, it must demonstrate that it is bioequivalent to the brand-name product. This means it must contain the same active ingredients and work in the body in the same way, but it may differ in inactive ingredients like colors or binders.

Q: What is the significance of the 'How Belic works' section for patients?

A: The mechanism section provides the rationale behind the medicine’s purpose. It explains that the analgesic component targets pain signals, while the antispasmodic component works on the muscle cramps, showing how the dual-action design is intended to address spasm-associated pain.

Q: Is Belic a controlled substance?

A: No. Official regulatory schedules for controlled substances do not classify the active ingredients, Acetaminophen (Paracetamol) and Hyoscine Butylbromide, as controlled substances.

Q: Are there any genetic factors that influence how Belic works?

A: Studies on the components, particularly the Acetaminophen component, suggest that genetic differences can affect its metabolism. This means that the rate at which the body processes the drug may vary among different individuals based on their genetic profile.

Q: What kind of monitoring is typically required while taking Belic?

A: The official label mandates that caution should be used in patients with pre-existing hepatic (liver) or renal (kidney) impairment. For these patients, a healthcare professional may require monitoring of liver and kidney function tests before or during treatment.

Q: How soon after stopping Belic do its effects wear off?

A: The medicine is designed for short-term relief, and its effects wear off relatively quickly. Based on pharmacokinetic data, the components have a short elimination half-life of just a few hours, meaning they are rapidly cleared from the body once the medicine is stopped.

Q: What is the regulatory status of Belic?

A: Belic is typically classified as a combination product. Due to the presence of Hyoscine Butylbromide and the need for medical supervision regarding the acetaminophen component, it is often available by prescription only in its fixed-dose form in many regions.

Q: What is the evidence regarding Belic's use in different ethnic groups?

A: While the combination product may lack specific studies focused on ethnicity, research on the individual components suggests that ethnic and gender differences can influence the way the drug is metabolized by the body. This is a point of ongoing scientific inquiry.

Q: Why do official sources sometimes use complex medical terms to describe Belic?

A: Regulatory documents like the Summary of Product Characteristics (SmPC) are required by law to use precise scientific language. This ensures clarity and accuracy when communicating the drug's exact mechanism and potential risks to healthcare professionals, who require this technical detail for proper prescription.

Q: Can Belic cause changes in my blood pressure?

A: The official list of adverse reactions includes tachycardia (increased heart rate). While not explicitly listing blood pressure changes, severe cases of hypotension (low blood pressure) have been reported with the antispasmodic component, making it a point of caution and monitoring.

How should Belic be stored and disposed of?

The official product labeling for Belic (Acetaminophen/Hyoscine Butylbromide tablets) defines precise conditions for storage and disposal to ensure stability and public safety.

Storage Requirements

The tablets must be stored at a controlled room temperature, which is officially defined as not exceeding 30 C. The product must be kept in its original container and protected from environmental factors, including light, moisture, and excessive heat. For safety, the medicine must be stored out of the sight and reach of children.

Disposal Instructions

Expired or unused tablets must not be thrown into household waste or flushed down the toilet, as stated in regulatory guidelines to prevent environmental contamination. Consumers are required to dispose of the medicine in accordance with local regulations, which typically means taking the product to a pharmacist or an authorized medicine take-back program for safe destruction.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Belic found in:

A-Z Index: